Medtech companies responding to the pandemic have had to dig deep, and when they have, they have often been rewarded in ways that have allowed management to view their company differently, and even see new opportunities.
Stryker CEO Kevin Lobo offered a good example of a group’s hidden depths being unearthed, and also how regulators and...